First human trial begins for potential eye disease pill
Disease control
Recruiting now
This is the first study in humans to test the safety of an oral tablet called DC6001, which is being developed for Stargardt disease—a genetic eye condition that causes vision loss. The trial will enroll 76 healthy Chinese adults to see how their bodies process different doses of…
Phase: PHASE1 • Sponsor: Heronova Pharmaceuticals • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC